Relmada Therapeutics, Inc.
RLMD
$4.80
$0.051.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 217.73M | 233.96M | 93.01M | 13.89M | 20.62M |
| Total Receivables | 10.90K | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.30M | 1.38M | 977.70K | 967.70K | 474.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 219.04M | 235.34M | 93.98M | 14.85M | 21.09M |
|
|
|||||
| Total Current Assets | 219.04M | 235.34M | 93.98M | 14.85M | 21.09M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 19.50K | 19.50K | 19.50K | 22.00K | 22.00K |
| Total Assets | 219.06M | 235.36M | 94.00M | 14.88M | 21.12M |
|
|
|||||
| Total Accounts Payable | 2.41M | 5.73M | 1.57M | 1.45M | 1.36M |
| Total Accrued Expenses | 5.01M | 7.16M | 4.86M | 3.74M | 3.77M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 7.42M | 12.89M | 6.43M | 5.19M | 5.13M |
|
|
|||||
| Total Current Liabilities | 7.42M | 12.89M | 6.43M | 5.19M | 5.13M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.08M | 3.74M | 1.06M | 221.10K | 32.10K |
| Total Liabilities | 12.50M | 16.63M | 7.49M | 5.41M | 5.17M |
|
|
|||||
| Common Stock & APIC | 936.79M | 936.05M | 784.78M | 687.87M | 684.26M |
| Retained Earnings | -730.23M | -717.32M | -698.27M | -678.40M | -668.31M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 206.56M | 218.73M | 86.51M | 9.47M | 15.95M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 206.56M | 218.73M | 86.51M | 9.47M | 15.95M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 206.56M | 218.73M | 86.51M | 9.47M | 15.95M |
|
|
|||||